pentobarbital will lower the extent or influence of buprenorphine subdermal implant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Closely. Keep track of clients previously on buprenorphine subdermal implant who require newly-initiated cure with CYP3A4 inducer for indications and signs and symptoms of withdra